Quote:

---

The Company can immediately initiate enrollment in this Phase 2 clinical trial for the treatment of approximately 22 different solid tumor cancers, including melanoma, brain-glioblastoma, throat, lung, stomach, colon carcinoma, breast, testicular, ovarian, uterine, pancreas, bladder, among other indications

---

You got there something, I just realized that now.

I quess they can only state something like that, if FDA agreed uppon on that right? Or are there cases known where enrolling can start before FDA approved the IND???

So filing the IND is more the formal step, but FDA will basically ok it, because they discussed everything with them already?